Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 82009-116

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 82009-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container100mg (Container100mg)

Container100mg (Container100mg)
Label for Metoprolol Succinate Extended-Release Tablets, USP 100 mg by Quallent Pharmaceuticals Health LLC. The film-coated tablets come in a bottle of 500 tablets. The label includes storage instructions, usage warnings, barcode, and manufacturing details listing Dr. Reddy's Laboratories Limited in India as the manufacturer.*
FDA Label Image

Container200mg (Container200mg)

Container200mg (Container200mg)
Label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg, film-coated tablets, with 500 count. Manufactured by Dr. Reddy's Laboratories Limited, India, and labeled for Quallent Pharmaceuticals Health LLC, Cayman Islands. Includes storage instructions and safety warnings.*
FDA Label Image

Figure (Figure)

Figure (Figure)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' displaying relative risk and 95% confidence intervals for subgroups comparing metoprolol succinate extended-release tablets versus placebo. Three outcomes are shown: Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure. Subgroups include demographics, clinical conditions, and heart function measures with risk favoring either treatment or placebo.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of metoprolol succinate, showing the molecular arrangement of its active ingredient components including the succinate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.